Clinical trial
A Randomized Controlled Trial to Evaluate Wound Complications After Primary Total Hip Arthroplasty Using Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh
NCT07868900 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial to Evaluate Wound Complications After Primary Total Hip Arthroplasty Using Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 15, 2026
- Completion date
- January 1, 2028
- Enrollment
- 350 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
allergic contact dermatitis (acd)